CAM
AMGN icon

Chesapeake Asset Management’s Amgen AMGN Stock Holding History

Chesapeake Asset Management’s Portfolio AMGN Stock Details AMGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-2
Closed -$5 – 538
2024
Q4 		$5 Hold
2
– – ﹤0.01% 522
2024
Q3 		$157 Hold
2
– – ﹤0.01% 508
2024
Q2 		$205 Hold
2
– – ﹤0.01% 327
2024
Q1 		$470 Buy
+2
New +$585 ﹤0.01% 298

Other funds holding AMGN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Chesapeake Asset Management's AMGN Position: Q4 2025 in Review

Chesapeake Asset Management sold out of Amgen (AMGN) in Q4 2025, closing a stake of 25 shares — an estimated $7.05K sold.

Chesapeake Asset Management first reported a position in AMGN in Q1 2023 and held it in 11 quarters. The position peaked at $176K in Q4 2023. 3,086 funds tracked by Wall St. Rank hold AMGN as of Q4 2025.

  • Chesapeake Asset Management reported no remaining Amgen position as of Q4 2025 after selling out during the quarter.
  • Chesapeake Asset Management sold 25 Amgen shares in Q4 2025, an estimated $7.05K.
  • Chesapeake Asset Management first reported a position in Amgen in Q1 2023 and held it in 11 quarters.
  • Chesapeake Asset Management's Amgen position peaked at $176K in Q4 2023.
  • 3,086 funds tracked by Wall St. Rank held Amgen as of Q4 2025.

Based on Chesapeake Asset Management's 13F filing for Q4 2025, filed 8 Jan 2026.